Edesa Biotech Statistics
Want to see EDSA full AI Analyst Report?
Edesa Biotech (EDSA) Stock Statistics & Valuation Metrics
Total Valuation
Edesa Biotech has a market cap or net worth of $27.29M. The enterprise value is $71.31M.
- Market Cap
- $27.29M
- Enterprise Value
- $71.31M
Share Statistics
Edesa Biotech has 13,511,531 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,511,531
- Owned by Insiders
- 15.85%
- Owned by Institutions
- 1.68%
Financial Efficiency
Edesa Biotech’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -63.54%.
- Return on Equity (ROE)
- -0.58
- Return on Assets (ROA)
- -0.53
- Return on Invested Capital (ROIC)
- -63.54%
- Return on Capital Employed (ROCE)
- -0.64
- Revenue Per Employee
- 0
- Profits Per Employee
- -422.68K
- Employee Count
- 17
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Edesa Biotech is -1.23. Edesa Biotech’s PEG ratio is 0.04.
- PE Ratio
- -1.23
- PS Ratio
- 0.00
- PB Ratio
- 2.13
- Price to FCF
- -2.24
- Price to Operating Cash Flow
- -2.09
- PEG Ratio
- 0.04
Income Statement
In the last 12 months, Edesa Biotech had revenue of 0 and earned -7.19M in profits. Earnings per share was -1.27.
- Revenue
- 0
- Gross Profit
- -119.27K
- Operating Income
- -7.91M
- Pretax Income
- -7.18M
- Net Income
- -7.19M
- EBITDA
- -7.07M
- Earnings Per Share (EPS)
- -1.27
Cash Flow
In the last 12 months, operating cash flow was -8.95M and capital expenditures 3, giving a free cash flow of -8.95M billion.
- Operating Cash Flow
- -8.95M
- Free Cash Flow
- -8.95M
- Free Cash Flow per Share
- -0.99
Dividends & Yields
Edesa Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -44.46%
- Earnings Yield
- -74.91%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- 16.20%
- 50-Day Moving Average
- 3.44
- 200-Day Moving Average
- 5.76
- Relative Strength Index (RSI)
- 37.47
- Average Volume (3m)
- 1.43M
Important Dates
Edesa Biotech upcoming earnings date is Dec 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Dec 11, 2026
- Ex-Dividend Date
- ―
Financial Position
Edesa Biotech as a current ratio of 10.67, with Debt / Equity ratio of 0.00%
- Current Ratio
- 10.67
- Quick Ratio
- 10.67
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.53
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Edesa Biotech has paid 800 in taxes.
- Income Tax
- 800
- Effective Tax Rate
- -0.00
Enterprise Valuation
Edesa Biotech EV to EBITDA ratio is -0.69, with an EV/FCF ratio of -1.09.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.69
- EV to Free Cash Flow
- -1.09
- EV to Operating Cash Flow
- -1.09
Balance Sheet
Edesa Biotech has $10.33M in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.33M billion.
- Cash & Marketable Securities
- $10.33M
- Total Debt
- $0.00
- Net Cash
- $10.33M
- Net Cash Per Share
- $0.76
- Tangible Book Value Per Share
- $0.77
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Edesa Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -27.34%
Scores
- Smart Score
- ―
- AI Score
- 43
